Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Clinical trial NCT01938456 · WITHDRAWN

Trial details

NCT number: NCT01938456
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2013-10-01
Primary completion: 2014-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.